Cargando…

Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol

BACKGROUND: Recent progress in the pathophysiology of heart failure (HF) has led to the development of new therapeutic options such as gene therapy and the use of adeno-associated viral (AAV) vectors. Despite the promising results in early clinical trials of gene therapy for HF, various obstacles ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rincon, Melvin Y, Prada, Carlos E, Lopez, Marcos, Castillo, Victor, Echeverria, Luis Eduardo, Serrano, Norma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2016
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919550/ https://www.ncbi.nlm.nih.gov/pubmed/27282359 http://dx.doi.org/10.2196/resprot.5535

Ejemplares similares

Prevalence of Neutralizing Antibodies against Adeno-Associated Virus Serotypes 1, 2, and 9 in Non-Injected Latin American Patients with Heart Failure—ANVIAS Study
por: Sierra-Delgado, Julieth A., et al.
Publicado: (2023)

Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an In Vitro Reporter System
por: Meliani, Amine, et al.
Publicado: (2015)

In utero intracerebroventricular delivery of adeno-associated viral vectors to target mouse choroid plexus and cerebrospinal fluid
por: Jang, Ahram, et al.
Publicado: (2022)

Adeno-Associated Viral Vectors in Neuroscience Research
por: Haggerty, David L., et al.
Publicado: (2019)

Production and Titering of Recombinant Adeno-associated Viral Vectors
por: McClure, Christina, et al.
Publicado: (2011)

Accurate Quantification and Characterization of Adeno-Associated Viral Vectors
por: Dobnik, David, et al.
Publicado: (2019)

Higher Seroprevalence of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies Among Racial Minorities in the United States
por: Khatri, Arpana, et al.
Publicado: (2022)

Alcohol use disorders and psychiatric diseases in Colombia
por: Rincon-Hoyos, Hernan G, et al.
Publicado: (2016)

Axonal transport of adeno-associated viral vectors is serotype-dependent
por: Salegio, Ernesto A., et al.
Publicado: (2012)

Biology of adeno-associated viral vectors in the central nervous system
por: Murlidharan, Giridhar, et al.
Publicado: (2014)

Manufacturing of recombinant adeno-associated viral vectors for clinical trials
por: Clément, Nathalie, et al.
Publicado: (2016)

Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity
por: Mingozzi, Federico, et al.
Publicado: (2015)

Adipose Tissue: An Emerging Target for Adeno-associated Viral Vectors
por: Bates, Rhiannon, et al.
Publicado: (2020)

Adeno-associated viral delivery of engineered tRNA-enzyme pairs into nonsense mutation mouse models
por: Zheng, Zhetao, et al.
Publicado: (2022)

Exclusive labeling of direct and indirect pathway neurons in the mouse neostriatum by an adeno-associated virus vector with Cre/lox system
por: Okamoto, Shinichiro, et al.
Publicado: (2020)

Manufacturing of recombinant adeno-associated viral vectors: new technologies are welcome
por: Ayuso, Eduard
Publicado: (2016)

Perinatal systemic gene delivery using adeno-associated viral vectors
por: Karda, Rajvinder, et al.
Publicado: (2014)

In Situ Detection of Adeno-associated Viral Vector Genomes with SABER-FISH
por: Wang, Sean K., et al.
Publicado: (2020)

GABAergic Gene Regulatory Elements Used in Adeno-Associated Viral Vectors
por: Duba-Kiss, Robert, et al.
Publicado: (2021)

Strong ubiquitous micro-promoters for recombinant adeno-associated viral vectors
por: Chai, Sunghee, et al.
Publicado: (2023)

Modifiers of Adeno-Associated Virus-Mediated Gene Expression in Implication for Serotype-Universal Neutralizing Antibody Assay
por: Krotova, Karina, et al.
Publicado: (2020)

Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity
por: Rossi, Axel, et al.
Publicado: (2019)

A Comparative Analysis of Constitutive Promoters Located in Adeno-Associated Viral Vectors
por: Damdindorj, Lkhagvasuren, et al.
Publicado: (2014)

Adeno-associated viral vectors do not efficiently target muscle satellite cells
por: Arnett, Andrea LH, et al.
Publicado: (2014)

DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations
por: Schnödt, Maria, et al.
Publicado: (2016)

In vivo imaging of adeno-associated viral vector labelled retinal ganglion cells
por: Smith, Corey A., et al.
Publicado: (2018)

Adeno-Associated Viral Vectors as a Tool for Large Gene Delivery to the Retina
por: Trapani, Ivana
Publicado: (2019)

Comparison of analytical techniques to quantitate the capsid content of adeno-associated viral vectors
por: Werle, Amanda K., et al.
Publicado: (2021)

Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors
por: Tickner, Zachary J., et al.
Publicado: (2021)

Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives
por: Fajardo-Serrano, Ana, et al.
Publicado: (2022)

Cardiovascular Risk and Its Associated Factors in Health Care Workers in Colombia: A Study Protocol
por: Gamboa Delgado, Edna M, et al.
Publicado: (2015)

Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector
por: Vermeij, J, et al.
Publicado: (2001)

Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies
por: Li, Ya, et al.
Publicado: (2019)

Fast-Seq: A Simple Method for Rapid and Inexpensive Validation of Packaged Single-Stranded Adeno-Associated Viral Genomes in Academic Settings
por: Maynard, Lucy H., et al.
Publicado: (2019)

Adeno-Associated Viral Vectors as Versatile Tools for Parkinson’s Research, Both for Disease Modeling Purposes and for Therapeutic Uses
por: Fajardo-Serrano, Ana, et al.
Publicado: (2021)

Adeno-Associated Viral Vector Serotype 5 Poorly Transduces Liver in Rat Models
por: Montenegro-Miranda, Paula S., et al.
Publicado: (2013)

An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy
por: Duncan, Gregg A., et al.
Publicado: (2018)

The Application of Adeno-Associated Viral Vector Gene Therapy to the Treatment of Fragile X Syndrome
por: Hampson, David R., et al.
Publicado: (2019)

Autophagy determines efficiency of liver‐directed gene therapy with adeno‐associated viral vectors
por: Hösel, Marianna, et al.
Publicado: (2017)

Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeutics
por: Mnyandu, Njabulo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hu5qrse3u6a8vj0bm808tuauv7